The Sorrento Team is committed to improving the lives of patients through the development of innovative cancer therapies. Our team is inspired and determined to the advancement of science, medicine and healthcare.
Among our employees, we count numerous PhD scientists, associate professors from highly respected medical institutions, but most importantly we are all dedicated to defeating cancer as it often resonates at a very personal level.
“I’ve lost my cousin and a very dear childhood friend to brain cancer (gliomas). There is no worst fate than fading away in a vegetative state, loaded with high doses of morphine. We should have better options than opioids for the treatment of terminal cancer pain – which is why the RTX project is exciting to me.”
– Dr. Alexis Nahama, Vice President of Corporate Development and President Ark Animal Health.